PSDV - pSivida Limited Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : PSDV - pSivida Limited

PSDV 1.220

+14.0%

Mar 29 5:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: John McCarthy	11/18/2009 11:11:46 AM
	Read Replies (1) of 421

Ladenburg Thalmann Initiates Coverage on pSivida (PSDV) with a Buy November 18, 2009 7:44 AM EST Ladenburg Thalmann initiates coverage on pSivida (Nasdaq: PSDV) with a Buy rating. Price target $9. To see all the upgrades/downgrades on shares of PSDV, visit our Analyst Ratings page. pSivida Corp., together with its subsidiaries, develops drug delivery products in the healthcare sector. streetinsider.com

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next